Results 1 to 6 of 6
Page 1 of 1
TypeTitleAuthor(s)YearViews
Entecavir (ETV) therapy in chronic hepatitis B patients previously treated with adefovir (ADV) with incomplete response on-treatment or relapse off-treatment.Lai, CL; Elion, R; Sherman, M; Hann, HW; Tyrell, DL; Hsu, CW; Tan, CK; Peng, CY; Leung, N; Mercarni, K; Zhang, H; Iloeje, UH; Kreter, B2009255
 
Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovirLeung, N; Peng, CY; Hann, HW; Sollano, J; LaoTan, J; Hsu, CW; Lesmana, L; Yuen, MF; Jeffers, L; Sherman, M; Min, A; Mencarini, K; Diva, U; Cross, A; Wilber, R; LopezTalavera, J2009420
 
Entecavir (ETV) Results in Higher HBV-DNA Reduction vs Adefovir (ADV) In Chronically Infected HBeAg(+) Antiviral-Naive Adults: 48-Week Results (E.A.R.L.Y. STUDY)Leung, N; Sherman, M; Peng, CY; Sollano, JD; Lesmana, L; Yuen, RMF; Jeffers, L; Hann, HW; Menearini, K; Colonno, R; Cross, A; Wilber, R; Lopez-Talavera, JC200798
 
Entecavir (ETV) vs. Adefovir (ADV): HBV DNA reduction of viral load in chronically infected HBeAg(+) nucleoside naive adults in a 12-weekSherman, M; Hann, HW; Jeffers, L; Min, A; Leung, N; Peng, CY; Liaw, YF; Sollano, J; Lesmana, L; Yuen, RMF; Zhu, J; Mencarini, K; Colonno, R; Cross, A; Wilber, R; Lopez-Talavera, JC2006122
 
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis BLai, CL; Leung, N; Teo, EK; Tong, M; Wong, F; Hann, HW; Han, S; Poynard, T; Myers, M; Chao, G; Lloyd, D; Brown, NA20051,182
 
Results of a One-year International Phase IIB Comparative Trial of Telbivudine, Lamivudine, and the Combination, in Patients with Chronic Hepatitis BLai, CL; Leung, NWY; Teo, EK; Tong, M; Wong, F; Hann, HW; Han, S; Poynard, T; Myers, M; Chao, G; Lloyd, D; Brown, N2003143
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download